Fingerprint
Dive into the research topics of 'In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Research output: Contribution to journal › Comment/debate › peer-review